PIK3CA c.370C>A ;(p.P124T)

Variant ID: 3-178917495-C-A

NM_006218.2(PIK3CA):c.370C>A;(p.P124T)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma.

Cancer Science
Tamura, Ryo R; Nakaoka, Hirofumi H; Yachida, Nozomi N; Ueda, Haruka H; Ishiguro, Tatsuya T; Motoyama, Teiichi T; Inoue, Ituro I; Enomoto, Takayuki T; Yoshihara, Kosuke K
Publication Date: 2023-02-10

Variant appearance in text: PIK3CA: 370C>A; Pro124Thr
PubMed Link: 36762791
Variant Present in the following documents:
  • CAS-114-2145-s001.xlsx, sheet 6
View BVdb publication page



Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer.

Cancer Biology & Medicine
Carter, Rebecca R; Cheraghchi-Bashi, Azadeh A; Westhorpe, Adam A; Yu, Sheng S; Shanneik, Yasmin Y; Seraia, Elena E; Ouaret, Djamila D; Inoue, Yasuhiro Y; Koch, Catherine C; Wilding, Jenny J; Ebner, Daniel D; Ryan, Anderson J AJ; Buffa, Francesca M FM; Sharma, Ricky A RA
Publication Date: 2019-05

Variant appearance in text: PIK3CA: P124T
PubMed Link: 31516745
Variant Present in the following documents:
  • cbm-16-2-234.pdf
View BVdb publication page



Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA.

Journal Of Medical Genetics
Peng, Muyun M; Xie, Yuancai Y; Li, Xiaohua X; Qian, Youhui Y; Tu, Xiaonian X; Yao, Xumei X; Cheng, Fangsheng F; Xu, Feiyue F; Kong, Deju D; He, Bing B; Liu, Chaoyu C; Cao, Fengjun F; Yang, Haoxian H; Yu, Fenglei F; Xu, Chuanbo C; Tian, Geng G
Publication Date: 2019-10

Variant appearance in text: PIK3CA: 370C>A; Pro124Thr
PubMed Link: 30981987
Variant Present in the following documents:
  • jmedgenet-2018-105825supp002.xlsx, sheet 4
View BVdb publication page



Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Nature Communications
Kis, Olena O; Kaedbey, Rayan R; Chow, Signy S; Danesh, Arnavaz A; Dowar, Mark M; Li, Tiantian T; Li, Zhihua Z; Liu, Jessica J; Mansour, Mark M; Masih-Khan, Esther E; Zhang, Tong T; Bratman, Scott V SV; Oza, Amit M AM; Kamel-Reid, Suzanne S; Trudel, Suzanne S; Pugh, Trevor J TJ
Publication Date: 2017-05-11

Variant appearance in text: PI3K: 370C>A
PubMed Link: 28492226
Variant Present in the following documents:
  • ncomms15086-s3.xlsx, sheet 1
View BVdb publication page



Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Coffee, Erin M EM; Faber, Anthony C AC; Roper, Jatin J; Sinnamon, Mark J MJ; Goel, Gautam G; Keung, Lily L; Wang, Wei Vivian WV; Vecchione, Loredana L; de Vriendt, Veerle V; Weinstein, Barbara J BJ; Bronson, Roderick T RT; Tejpar, Sabine S; Xavier, Ramnik J RJ; Engelman, Jeffrey A JA; Martin, Eric S ES; Hung, Kenneth E KE
Publication Date: 2013-05-15

Variant appearance in text: PIK3CA: P124T
PubMed Link: 23549875
Variant Present in the following documents:
  • Main text
View BVdb publication page



Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research
Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C
Publication Date: 2011-09-01

Variant appearance in text: PIK3CA: P124T
PubMed Link: 21727090
Variant Present in the following documents:
  • supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1
View BVdb publication page



Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Cancer Metastasis Reviews
Knowles, Margaret A MA; Platt, Fiona M FM; Ross, Rebecca L RL; Hurst, Carolyn D CD
Publication Date: 2009-12

Variant appearance in text: PIK3CA: P124T
PubMed Link: 20013032
Variant Present in the following documents:
  • Main text
  • 10555_2009_Article_9198.pdf
View BVdb publication page